Andrea Toja
University of Perugia(IT)
Publications by Year
Research Areas
Dementia and Cognitive Impairment Research, Alzheimer's disease research and treatments, Parkinson's Disease Mechanisms and Treatments, Neurological disorders and treatments, Cerebrospinal fluid and hydrocephalus
Most-Cited Works
- → Investigating alpha‐synuclein co‐pathology in Alzheimer's disease by means of cerebrospinal fluid alpha‐synuclein seed amplification assay(2024)86 cited
- → Trajectories of CSF and plasma biomarkers across Alzheimer's disease continuum: disease staging by NF-L, p-tau181, and GFAP(2023)50 cited
- → Fully automated measurement of plasma Aβ42/40 and p‐tau181: Analytical robustness and concordance with cerebrospinal fluid profile along the Alzheimer's disease continuum in two independent cohorts(2024)39 cited
- → CSF and plasma Aβ42/40 across Alzheimer’s disease continuum: comparison of two ultrasensitive Simoa® assays targeting distinct amyloid regions(2023)14 cited
- → Potential diagnostic value of CSF metabolism-related proteins across the Alzheimer’s disease continuum(2023)13 cited
- → Diagnostic performance of plasma Aβ42/40 ratio, p‐tau181, GFAP, and NfL along the continuum of Alzheimer's disease and non‐AD dementias: An international multi‐center study(2025)13 cited
- → Increased plasma DOPA decarboxylase levels in Lewy body disorders are driven by dopaminergic treatment(2025)12 cited
- → Aquaporin-4 as a cerebrospinal fluid biomarker of Alzheimer’s disease(2024)11 cited
- → Association of αS-SAA kinetics with clinical scores in the clinical spectrum of Parkinson's disease(2025)4 cited
- → Subtle cognitive deficits assessed by means of CANTAB in a cohort of subjects with CSF AD profile(2022)3 cited